Short Interest in Integrated BioPharma, Inc. (OTCMKTS:INBP) Expands By 1,500.0%

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 4,800 shares, a growth of 1,500.0% from the February 28th total of 300 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 16,900 shares, the days-to-cover ratio is currently 0.3 days.

Integrated BioPharma Stock Up 13.3 %

INBP traded up $0.04 during trading hours on Wednesday, hitting $0.34. The stock had a trading volume of 17,845 shares, compared to its average volume of 19,815. Integrated BioPharma has a 1 year low of $0.16 and a 1 year high of $0.42. The company’s fifty day simple moving average is $0.33 and its 200 day simple moving average is $0.31. The stock has a market cap of $10.30 million, a PE ratio of 11.34 and a beta of 0.89.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.